STAT

Pregnancy reported in the first known trial of ‘three-person IVF’ for infertility

A Greek woman is reportedly pregnant from a reproductive technique that uses DNA from three people — as part of the first known clinical trial to use the procedure to…

A 32-year-old Greek woman is reportedly pregnant from an experimental reproductive technique that uses DNA from three people — as part of the first known clinical trial to use the controversial procedure to treat infertility.

The procedure, known as mitochondrial replacement therapy, is banned in the U.S., because of concerns that introduction of DNA from a third “parent” into an embryo is a form of genetic modification that could affect generations to come.

The first baby conceived with this technique was born in 2016, but in that case the purpose was to allow parents to have a child without passing on a genetic mutation that, but it is not part of a formal trial. If the method works better than conventional in vitro fertilization to treat infertility, it could lead to a radical new way to have children for older women and those struggling to get pregnant.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About MDMA For PTSD, A CRISPR Treatment For Blindness, And More
An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.

Related Books & Audiobooks